NAT2 and tuberculosis: Zazuli et al. [36] and Wang et al. [47] showed that patients carrying the rs3814055 TT genotype or T allele in conjunction with NAT2 non-slow acetylator status, respectively, are more susceptible to anti-TB treatment-associated DILI, but another group of investigators described a protective effect [41].